{"DataElement":{"publicId":"5040724","version":"1","preferredName":"Chronic Graft Versus Host Disease Lung Involvement NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"Information related to the NIH Consensus Response Criteria for cGVHD severity of lung involvement.","longName":"5040568v1.0:5040723v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5040568","version":"1","preferredName":"Chronic Graft Versus Host Disease Lung Involvement","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation._One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._To have a connection by participation or association or use; sharing in an activity or process.","longName":"5040566v1.0:2192548v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5040566","version":"1","preferredName":"Chronic Graft Versus Host Disease Lung","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.:One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","longName":"C4981:C12468","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-473F-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192548","version":"1","preferredName":"Involvement","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F4C3B9-9218-0989-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-29","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-474D-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"COOPERM","dateModified":"2016-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5040723","version":"1","preferredName":"Lung NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252-266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999)._Used of the degree of something undesirable e.g. pain or weather; also, strictness._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"5040723v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Score 2","valueDescription":"Moderate Symptom","ValueMeaning":{"publicId":"5145212","version":"1","preferredName":"Moderate Symptom","longName":"5145212","preferredDefinition":"The quality of being within reasonable or average limits; not excessive or extreme.: Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate","conceptCode":"C61376","definition":"The quality of being within reasonable or average limits; not excessive or extreme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D11EB05-E3D6-5B04-E050-BB89AD433122","latestVersionIndicator":"Yes","beginDate":"2016-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-02","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2D11EB05-E3EF-5B04-E050-BB89AD433122","beginDate":"2016-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-02","modifiedBy":"ONEDATA","dateModified":"2016-03-02","deletedIndicator":"No"},{"value":"Score 3","valueDescription":"Severe Symptom","ValueMeaning":{"publicId":"5145211","version":"1","preferredName":"Severe Symptom","longName":"5145211","preferredDefinition":"Intensely bad or unpleasant in degree, quality or extent.: Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe","conceptCode":"C70667","definition":"Intensely bad or unpleasant in degree, quality or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D11EB05-E3B3-5B04-E050-BB89AD433122","latestVersionIndicator":"Yes","beginDate":"2016-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-02","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2D11EB05-E3CC-5B04-E050-BB89AD433122","beginDate":"2016-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-02","modifiedBy":"ONEDATA","dateModified":"2016-03-02","deletedIndicator":"No"},{"value":"Score 1","valueDescription":"Mild Symptom","ValueMeaning":{"publicId":"5145213","version":"1","preferredName":"Mild Symptom","longName":"5145213","preferredDefinition":"Gentle or temperate in nature or degree.: Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild","conceptCode":"C70666","definition":"Gentle or temperate in nature or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2D11EB05-E3F9-5B04-E050-BB89AD433122","latestVersionIndicator":"Yes","beginDate":"2016-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-02","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2D11EB05-E412-5B04-E050-BB89AD433122","beginDate":"2016-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-02","modifiedBy":"ONEDATA","dateModified":"2016-03-02","deletedIndicator":"No"},{"value":"Score 0","valueDescription":"No Symptom","ValueMeaning":{"publicId":"3905686","version":"1","preferredName":"No Symptom","longName":"3905686","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6C39D49-28C2-B42C-E040-BB89AD432F1B","latestVersionIndicator":"Yes","beginDate":"2013-09-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-19","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2D11EB05-E426-5B04-E050-BB89AD433122","beginDate":"2016-03-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-02","modifiedBy":"ONEDATA","dateModified":"2016-03-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5042838","version":"1","preferredName":"Lung NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.:A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252¿266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999).:Severity; used of the degree of something undesirable e.g. pain or weather.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C12468:C103138:C25676:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"NIH Consensus Response Criteria for Chronic GVHD","conceptCode":"C103138","definition":"A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252-266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23CDAD6E-898D-342E-E050-BB89AD437A8E","latestVersionIndicator":"Yes","beginDate":"2015-11-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-05","modifiedBy":"ONEDATA","dateModified":"2015-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2355820E-27D8-AAFA-E050-BB89AD432004","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"HPST_CGHD_cgvhd_lung_NIH_score","type":"NMDP_FN","context":"NHLBI"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"What is the NIH Consensus Res","type":"Preferred Question Text","description":"What is the NIH Consensus Response Criteria for cGVHD severity of lung involvement?","url":null,"context":"NHLBI"},{"name":"Lung score","type":"Alternate Question Text","description":"Lung score","url":null,"context":"NHLBI"},{"name":"Lung score","type":"Application Standard Question Text","description":"Lung score","url":null,"context":"NHLBI"},{"name":"NIH lung score","type":"Alternate Question Text","description":"NIH lung score","url":null,"context":"NHLBI"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Lungs (Symptom score):","url":null,"context":"COG"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2355820E-2835-AAFA-E050-BB89AD432004","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"MAESKEB","dateModified":"2022-03-31","changeDescription":".AQT added for 2100r7. 04/23/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}